Top Markets
#1 Black Phoenix Black Phoenix +167.81%
#2 Islamic Coin Islamic Coin +158.25%
#3 Glidr Glidr +84.34%
#4 Test Test +25.75%
#5 Cryptopia Cryptopia +21.17%
#6 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.42%
#7 Quantum Resistant Ledger Quantum Resistant Ledger +15.72%
#8 Wrapped Bitcoin (PulseChain) Wrapped Bitcoin (PulseChain) +11.04%
#9 MarsCoin MarsCoin +9.74%
#10 stake.link stake.link +9.09%
Coin of the day
Black Phoenix Black Phoenix
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Comera Life Sciences Holdings, Inc. Comera Life Sciences Holdings, Inc.

Comera Life Sciences Holdings, Inc.

CMRAW
Clasificación en acciones #41593
Comera Life Sciences Holdings, Inc. is an early-stage life sciences company... Comera Life Sciences Holdings, Inc. is an early-stage life sciences company dedicated to developing its own innovative therapeutics. These treatments leverage its unique SQore formulation platform, which is engineered to convert biologics typically administered intravenously (IV) into convenient subcutaneous (SQ) versions. The company's pipeline currently features two primary drug candidates: CLS-001, an improved biologic in preclinical development, targets Crohn's and Ulcerative Colitis; and CLS-002, also in preclinical stages, is an enhanced biologic aimed at various oncological indications. Established in 2014, Comera Life Sciences is based in Woburn, Massachusetts.
Precio por acción
$0.0008
Última sincronización: 2024-03-14
Capitalización bursátil
$15.27K
Cambio (1 día)
0.00%
Cambio (1 año)
0.00%
País
US
Comercio Comera Life Sciences Holdings, Inc. (CMRAW)

Categoría

Healthcare
Ganancias de Comera Life Sciences Holdings, Inc. (CMRAW)
Ganancias en 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Comera Life Sciences Holdings, Inc., gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, igual a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de Comera Life Sciences Holdings, Inc. desde 2026 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
Not enough data for the provided dates.
Ganancias de empresas similares o competidoras
Empresa Ganancias Diferencia de ganancias País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B -
BE
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR